Global Crotamiton Cream Market Growth 2024-2030

Global Crotamiton Cream Market Growth 2024-2030

Product Code:1246490

Published Date: Dec 22,2024

Pages: 141

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global Crotamiton Cream market size is predicted to grow from US$ 33 million in 2024 to US$ 42.1 million in 2030; it is expected to grow at a CAGR of 4.1% from 2024 to 2030.

Crotamiton cream is an external-use drug, the main ingredient of which is crotamiton, used to treat skin pruritus and scabies. Crotamiton has a dual mechanism of action of antipruritic and insecticidal, which can effectively relieve skin pruritus caused by various reasons and has a direct killing effect on scabies mites. The cream has a mild texture and is easy to apply. It is suitable for adults and children. It is often recommended to treat local skin itching, itching associated with eczema, and scabies infection, helping patients restore skin health.

United States market for Crotamiton Cream is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Crotamiton Cream is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Crotamiton Cream is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Crotamiton Cream players cover Fuyuan Pharmaceutical Co., Ltd., Zhuhai Ansheng Phoenix Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., Changzhou Siyao Pharmaceutical Co., Ltd., Henan Daxin Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Crotamiton Cream Industry Forecast” looks at past sales and reviews total world Crotamiton Cream sales in 2023, providing a comprehensive analysis by region and market sector of projected Crotamiton Cream sales for 2024 through 2030. With Crotamiton Cream sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Crotamiton Cream industry.

This Insight Report provides a comprehensive analysis of the global Crotamiton Cream landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Crotamiton Cream portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Crotamiton Cream market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Crotamiton Cream and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Crotamiton Cream.

This report presents a comprehensive overview, market shares, and growth opportunities of Crotamiton Cream market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Compound Preparations
    Conventional Preparations

Segmentation by Application:
    Hospital
    Clinic
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Fuyuan Pharmaceutical Co., Ltd.
    Zhuhai Ansheng Phoenix Pharmaceutical Co., Ltd.
    Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.
    Changzhou Siyao Pharmaceutical Co., Ltd.
    Henan Daxin Pharmaceutical Co., Ltd.
    Tianjin Tianjiao Pharmaceutical Co., Ltd.
    Jiangxi Decheng Pharmaceutical Co., Ltd.
    Jiangxi Hillconta Pharmaceutical Co., Ltd.
    Beijing Shuangji Pharmaceutical Co., Ltd.
    Liaoning Huarui United Pharmaceutical Co., Ltd.
    Mentholatum (China) Pharmaceutical Co., Ltd.
    Shaanxi Han Tang Pharmaceutical Co., Ltd.
    Dingfukang Pharmaceutical Co., Ltd.
    Vitasv Pharma
    Thornton & Ross Ltd
    AS Pharmaceutical

Key Questions Addressed in this Report
What is the 10-year outlook for the global Crotamiton Cream market?
What factors are driving Crotamiton Cream market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Crotamiton Cream market opportunities vary by end market size?
How does Crotamiton Cream break out by Type, by Application?